The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.
Protein‐misfolding diseases and chaperone‐based therapeutic approaches
Abstract
A large number of neurodegenerative diseases in humans result from protein misfolding and aggregation. Protein misfolding is believed to be the primary cause of Alzheimer's disease, Parkinson's disease, Huntington's disease, Creutzfeldt–Jakob disease, cystic fibrosis, Gaucher's disease and many other degenerative and neurodegenerative disorders. Cellular molecular chaperones, which are ubiquitous, stress‐induced proteins, and newly found chemical and pharmacological chaperones have been found to be effective in preventing misfolding of different disease‐causing proteins, essentially reducing the severity of several neurodegenerative disorders and many other protein‐misfolding diseases. In this review, we discuss the probable mechanisms of several protein‐misfolding diseases in humans, as well as therapeutic approaches for countering them. The role of molecular, chemical and pharmacological chaperones in suppressing the effect of protein misfolding‐induced consequences in humans is explained in detail. Functional aspects of the different types of chaperones suggest their uses as potential therapeutic agents against different types of degenerative diseases, including neurodegenerative disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Principles that Govern the Folding of Protein Chains
Anfinsen, C. B. (1973) · Science · doi:10.1126/science.181.4096.223 · Cited by 7,096
Prusiner, S. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13363 · Cited by 5,373
Identification of the Cystic Fibrosis Gene: Genetic Analysis
Kerem, B.-S., Rommens, J. M., Buchanan, J. A., Markiewicz, D., Cox, T. K., Chakravarti, A., Buchwald, M., & Tsui, L.-C. (1989) · Science · doi:10.1126/science.2570460 · Cited by 4,142
Molecular Chaperones in the Cytosol: from Nascent Chain to Folded Protein
Hartl, F. U., & Hayer-Hartl, M. (2002) · Science · doi:10.1126/science.1068408 · Cited by 3,347
Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P. (1994) · Science · doi:10.1126/science.8023157 · Cited by 2,551
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516
Jarrett, J. T., & Lansbury, P. T. (1993) · Cell · doi:10.1016/0092-8674(93)90635-4 · Cited by 2,178
Microtubule Assembly in the Absence of Added Nucleotides
Shelanski, M. L., Gaskin, F., & Cantor, C. R. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.3.765 · Cited by 2,053
Protein misfolding, evolution and disease
Dobson, C. M. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01445-0 · Cited by 1,952
Aggresomes, inclusion bodies and protein aggregation
Kopito, R. R. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01852-3 · Cited by 1,921
Harper, J. D., & Lansbury, P. T. (1997) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.66.1.385 · Cited by 1,652
Zhuchenko, O., Bailey, J., Bonnen, P., Ashizawa, T., Stockton, D. W., Amos, C., Dobyns, W. B., Subramony, S. H., Zoghbi, H. Y., & Lee, C. C. (1997) · Nature Genetics · doi:10.1038/ng0197-62 · Cited by 1,583
Curcumin has potent anti‐amyloidogenic effects for Alzheimer's β‐amyloid fibrils in vitro
Ono, K., Hasegawa, K., Naiki, H., & Yamada, M. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20025 · Cited by 1,254
Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive
Denning, G. M., Anderson, M. P., Amara, J. F., Marshall, J., Smith, A. E., & Welsh, M. J. (1992) · Nature · doi:10.1038/358761a0 · Cited by 1,234
Chaperone Suppression of α-Synuclein Toxicity in a Drosophila Model for Parkinson's Disease
Auluck, P. K., Chan, H. Y. E., Trojanowski, J. Q., Lee, V. M.-Y., & Bonini, N. M. (2002) · Science · doi:10.1126/science.1067389 · Cited by 1,227
Mechanism of protein stabilization by glycerol: preferential hydration in glycerol-water mixtures
Gekko, K., & Timasheff, S. N. (1981) · Biochemistry · doi:10.1021/bi00519a023 · Cited by 1,181
Protein aggregation: folding aggregates, inclusion bodies and amyloid
Fink, A. L. (1998) · Folding and Design · doi:10.1016/s1359-0278(98)00002-9 · Cited by 1,157
A point mutation of the rhodopsin gene in one form of retinitis pigmentosa
Dryja, T. P., McGee, T. L., Reichel, E., Hahn, L. B., Cowley, G. S., Yandell, D. W., Sandberg, M. A., & Berson, E. L. (1990) · Nature · doi:10.1038/343364a0 · Cited by 1,072
Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis
Booth, D. R., Sunde, M., Bellotti, V., Robinson, C. V., Hutchinson, W. L., Fraser, P. E., Hawkins, P. N., Dobson, C. M., Radford, S. E., Blake, C. C. F., et al. (1997) · Nature · doi:10.1038/385787a0 · Cited by 1,048
Role of the Chaperone Protein Hsp104 in Propagation of the Yeast Prion-Like Factor [ psi + ]
Chernoff, Y. O., Lindquist, S. L., Ono, B.-I., Inge-Vechtomov, S. G., & Liebman, S. W. (1995) · Science · doi:10.1126/science.7754373 · Cited by 1,027
Cellular Defenses against Unfolded Proteins
Sherman, M. Y., & Goldberg, A. L. (2001) · Neuron · doi:10.1016/s0896-6273(01)00177-5 · Cited by 991
Intranuclear Inclusions of Expanded Polyglutamine Protein in Spinocerebellar Ataxia Type 3
Paulson, H. L., Perez, M. K., Trottier, Y., Trojanowski, J. Q., Subramony, S. H., Das, S. S., Vig, P., Mandel, J.-L., Fischbeck, K. H., & Pittman, R. N. (1997) · Neuron · doi:10.1016/s0896-6273(00)80943-5 · Cited by 830
Therapeutic approaches to protein-misfolding diseases
Cohen, F. E., & Kelly, J. W. (2003) · Nature · doi:10.1038/nature02265 · Cited by 800
Pharmacological Rescue of Mutant p53 Conformation and Function
Foster, B. A., Coffey, H. A., Morin, M. J., & Rastinejad, F. (1999) · Science · doi:10.1126/science.286.5449.2507 · Cited by 799
Neurodegenerative Diseases and Prions
Prusiner, S. B. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105173442006 · Cited by 772
3D domain swapping: A mechanism for oligomer assembly
Bennett, M. J., Schlunegger, M. P., & Eisenberg, D. (1995) · Protein Science · doi:10.1002/pro.5560041202 · Cited by 764
Sanpei, K., Takano, H., Igarashi, S., Sato, T., Oyake, M., Sasaki, H., Wakisaka, A., Tashiro, K., Ishida, Y., Ikeuchi, T., et al. (1996) · Nature Genetics · doi:10.1038/ng1196-277 · Cited by 763
α-Synuclein Promotes Mitochondrial Deficit and Oxidative Stress
Hsu, L. J., Sagara, Y., Arroyo, A., Rockenstein, E., Sisk, A., Mallory, M., Wong, J., Takenouchi, T., Hashimoto, M., & Masliah, E. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64553-1 · Cited by 714
HSP100/Clp proteins: a common mechanism explains diverse functions
Schirmer, E. C., Glover, J. R., Singer, M. A., & Lindquist, S. (1996) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(96)10038-4 · Cited by 673
Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease
Korth, C., May, B. C. H., Cohen, F. E., & Prusiner, S. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161274798 · Cited by 673
Expanded Polyglutamine Protein Forms Nuclear Inclusions and Causes Neural Degeneration in Drosophila
Warrick, J. M., Paulson, H. L., Gray-Board, G. L., Bui, Q. T., Fischbeck, K. H., Pittman, R. N., & Bonini, N. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81200-3 · Cited by 668
Fan, J.-Q., Ishii, S., Asano, N., & Suzuki, Y. (1999) · Nature Medicine · doi:10.1038/4801 · Cited by 614
Support for the Prion Hypothesis for Inheritance of a Phenotypic Trait in Yeast
Patino, M. M., Liu, J.-J., Glover, J. R., & Lindquist, S. (1996) · Science · doi:10.1126/science.273.5275.622 · Cited by 611
Mogk, A. (1999) · The EMBO Journal · doi:10.1093/emboj/18.24.6934 · Cited by 595
Alternative conformations of amyloidogenic proteins govern their behavior
Kelly, J. W. (1996) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(96)80089-3 · Cited by 593
Goloubinoff, P., Mogk, A., Zvi, A. P. B., Tomoyasu, T., & Bukau, B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.13732 · Cited by 582
Dityrosine Cross-linking Promotes Formation of Stable α-Synuclein Polymers
Souza, J. M., Giasson, B. I., Chen, Q., Lee, V. M.-Y., & Ischiropoulos, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000206200 · Cited by 563
Expanded polyglutamine in the Machado–Joseph disease protein induces cell death in vitro and in vivo
Ikeda, H., Yamaguchi, M., Sugai, S., Aze, Y., Narumiya, S., & Kakizuka, A. (1996) · Nature Genetics · doi:10.1038/ng0696-196 · Cited by 545
Jackson, G. R., Salecker, I., Dong, X., Yao, X., Arnheim, N., Faber, P. W., MacDonald, M. E., & Zipursky, S. L. (1998) · Neuron · doi:10.1016/s0896-6273(00)80573-5 · Cited by 533
PATHOLOGIC CONFORMATIONS OF PRION PROTEINS
Cohen, F. E., & Prusiner, S. B. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.793 · Cited by 533
Defective protein folding as a basis of human disease
Thomas, P. J., Qu, B.-H., & Pedersen, P. L. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)89100-8 · Cited by 529
Kinetic theory of fibrillogenesis of amyloid β-protein
Lomakin, A., Teplow, D. B., Kirschner, D. A., & Benedek, G. B. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.7942 · Cited by 529
Glycerol Reverses the Misfolding Phenotype of the Most Common Cystic Fibrosis Mutation
Sato, S., Ward, C. L., Krouse, M. E., Wine, J. J., & Kopito, R. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.635 · Cited by 519
Sawkar, A. R., Cheng, W.-C., Beutler, E., Wong, C.-H., Balch, W. E., & Kelly, J. W. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192582899 · Cited by 503
Identification of the cystic fibrosis gene.
Knight, R. A., & Hodson, M. E. (1990) · BMJ · doi:10.1136/bmj.300.6721.345 · Cited by 496
Influence of molecular and chemical chaperones on protein folding
Welch, W. J., & Brown, C. R. (1996) · Cell Stress & Chaperones · doi:10.1379/1466-1268(1996)001<0109:iomacc>2.3.co;2 · Cited by 495
Structural Clues to Prion Replication
Cohen, F. E., Pan, K.-M., Huang, Z., Baldwin, M., Fletterick, R. J., & Prusiner, S. B. (1994) · Science · doi:10.1126/science.7909169 · Cited by 468
The A53T α-Synuclein Mutation Increases Iron-Dependent Aggregation and Toxicity
Ostrerova-Golts, N., Petrucelli, L., Hardy, J., Lee, J. M., Farer, M., & Wolozin, B. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-16-06048.2000 · Cited by 466
Oltersdorf, T., Fritz, L. C., Schenk, D. B., Lieberburg, I., Johnson-Wood, K. L., Beattie, E. C., Ward, P. J., Blacher, R. W., Dovey, H. F., & Sinha, S. (1989) · Nature · doi:10.1038/341144a0 · Cited by 460
The Cystic Fibrosis Transmembrane Conductance Regulator
Riordan, J. R. (1993) · Annual Review of Physiology · doi:10.1146/annurev.ph.55.030193.003141 · Cited by 446
Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection
Zanata, S. M. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf325 · Cited by 445
Burrows, J. A. J., Willis, L. K., & Perlmutter, D. H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1796 · Cited by 426
Molecular Basis of the Neurodegenerative Disorders
Martin, J. B. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906243402507 · Cited by 418
Brown, C. R., Hong-Brown, L. Q., Biwersi, J., Verkman, A. S., & Welch, W. J. (1996) · Cell Stress & Chaperones · doi:10.1379/1466-1268(1996)001<0117:ccctmp>2.3.co;2 · Cited by 417
Biosynthesis and Degradation of CFTR
KOPITO, R. R. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.s167 · Cited by 410
Skowyra, D., Georgopoulos, C., & Zylicz, M. (1990) · Cell · doi:10.1016/0092-8674(90)90268-j · Cited by 406
Blake, C., & Serpell, L. (1996) · Structure · doi:10.1016/s0969-2126(96)00104-9 · Cited by 376
Cellular prion protein transduces neuroprotective signals
Chiarini, L. B. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf324 · Cited by 376
Identification and characterization of the gene causing type 1 spinocerebellar ataxia
Banfi, S., Servadio, A., Chung, M.-Y., Kwiatkowski, T. J., McCall, A. E., Duvick, L. A., Shen, Y., Roth, E. J., Orr, H. T., & Zoghbi, H. Y. (1994) · Nature Genetics · doi:10.1038/ng0894-513 · Cited by 373
Dimethyl sulphoxide: A review of its applications in cell biology
Yu, Z. W., & Quinn, P. J. (1994) · Bioscience Reports · doi:10.1007/bf01199051 · Cited by 353
Tomoyasu, T., Mogk, A., Langen, H., Goloubinoff, P., & Bukau, B. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02383.x · Cited by 337
Protein misfolding and disease; protein refolding and therapy
Soto, C. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02486-3 · Cited by 336
Tamarappoo, B. K., & Verkman, A. S. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2303 · Cited by 329
Autosomal dominant cerebellar ataxia: Phenotypic differences in genetically defined subtypes?
Schöls, L., Amoiridis, G., Büttner, T., Przuntek, H., Epplen, J. T., & Riess, O. (1997) · Annals of Neurology · doi:10.1002/ana.410420615 · Cited by 327
Parkin Localizes to the Lewy Bodies of Parkinson Disease and Dementia with Lewy Bodies
Schlossmacher, M. G., Frosch, M. P., Gai, W. P., Medina, M., Sharma, N., Forno, L., Ochiishi, T., Shimura, H., Sharon, R., Hattori, N., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61113-3 · Cited by 325
Protein Misfolding, Amyloid Formation, and Neurodegeneration
Muchowski, P. J. (2002) · Neuron · doi:10.1016/s0896-6273(02)00761-4 · Cited by 308
Roles of molecular chaperones in protein misfolding diseases
Barral, J. M., Broadley, S. A., Schaffar, G., & Hartl, F. U. (2004) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2003.12.010 · Cited by 295
Chemical chaperones interfere with the formation of scrapie prion protein.
Tatzelt, J., Prusiner, S. B., & Welch, W. J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01027.x · Cited by 294
David, G. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.2.165 · Cited by 278
Mutations and off-pathway aggregation of proteins
Wetzel, R. (1994) · Trends in Biotechnology · doi:10.1016/0167-7799(94)90082-5 · Cited by 262
Tau truncation during neurofibrillary tangle evolution in Alzheimer’s disease
Guillozet-Bongaarts, A. L., Garcia-Sierra, F., Reynolds, M. R., Horowitz, P. M., Fu, Y., Wang, T., Cahill, M. E., Bigio, E. H., Berry, R. W., & Binder, L. I. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.09.019 · Cited by 256
De novo expansion of a (CAG)n repeat in sporadic Huntington's disease
Myers, R. H., MacDonald, M. E., Koroshetz, W. J., Duyao, M. P., Ambrose, C. M., Taylor, S. A. M., Barnes, G., Srinidhi, J., Lin, C. S., Whaley, W. L., et al. (1993) · Nature Genetics · doi:10.1038/ng1093-168 · Cited by 244
Pharmacological chaperones: a new twist on receptor folding
Morello, J.-P., Bouvier, M., Petäjä-Repo, U. E., & Bichet, D. G. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01575-3 · Cited by 241
Ben-Zvi, A. P., & Goloubinoff, P. (2001) · Journal of Structural Biology · doi:10.1006/jsbi.2001.4352 · Cited by 241
TAN, S. Y., & PEPYS, M. B. (1994) · Histopathology · doi:10.1111/j.1365-2559.1994.tb00001.x · Cited by 230
Recent advances in the genetics and pathogenesis of Parkinson disease
Mouradian, M. M. (2002) · Neurology · doi:10.1212/wnl.58.2.179 · Cited by 228
Correction of Defective Protein Kinesis of Human P-glycoprotein Mutants by Substrates and Modulators
Loo, T. W., & Clarke, D. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.2.709 · Cited by 224
Nature and frequency of mutations in the alpha-galactosidase A gene that cause Fabry disease.
Eng, C. M., Resnick‐Silverman, L., Niehaus, D. J., Astrin, K. H., & Desnick, R. J. (1993) · PubMed · Cited by 220
da Costa, C. A., Ancolio, K., & Checler, F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002413200 · Cited by 213
Structural Aspects of the p53 Protein in Relation to Gene Evolution: A Second Look
Soussi, T., & May, P. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0425 · Cited by 208
Walker, D. R., Bond, J. P., Tarone, R. E., Harris, C. C., Makalowski, W., Boguski, M. S., & Greenblatt, M. S. (1999) · Oncogene · doi:10.1038/sj.onc.1202298 · Cited by 198
LONDON, J., SKRZYNIA, C., & GOLDBERG, M. E. (1974) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1974.tb03707.x · Cited by 197
Gametic but not somatic instability of CAG repeat length in Huntington's disease.
MacDonald, M. E., Barnes, G., Srinidhi, J., Duyao, M. P., Ambrose, C. M., Myers, R. H., Gray, J., Conneally, P. M., Young, A., & Penney, J. (1993) · Journal of Medical Genetics · doi:10.1136/jmg.30.12.982 · Cited by 194
Kienlen-Campard, P., Miolet, S., Tasiaux, B., & Octave, J.-N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200887200 · Cited by 187
Neurodegenerative disorders of protein aggregation
Shastry, B. S. (2003) · Neurochemistry International · doi:10.1016/s0197-0186(02)00196-1 · Cited by 186
‘Unfolding’ pathways in neurodegenerative disease
Forman, M. S., Lee, V. M.-Y., & Trojanowski, J. Q. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00197-8 · Cited by 182
Turnell, W. G., & Finch, J. T. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)90532-o · Cited by 179
Berke, S. J. S., & Paulson, H. L. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(03)00053-4 · Cited by 178
Correcting temperature-sensitive protein folding defects
Brown, C. R., Hong-Brown, L. Q., & Welch, W. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119302 · Cited by 176
(2000) · doi:10.1016/s0306-4522(00)00077-4 · Cited by 167
Ishii, S., Nakao, S., Minamikawa‐Tachino, R., Desnick, R. J., & Fan, J. (2002) · The American Journal of Human Genetics · doi:10.1086/339431 · Cited by 164
Ellis, R. J., & Pinheiro, T. J. T. (2002) · Nature · doi:10.1038/416483a · Cited by 161
Potent inhibition of scrapie prion replication in cultured cells by bis-acridines
May, B. C. H., Fafarman, A. T., Hong, S. B., Rogers, M., Deady, L. W., Prusiner, S. B., & Cohen, F. E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2627988100 · Cited by 159
Mechanism of rescue of common p53 cancer mutations by second‐site suppressor mutations
Nikolova, P. V., Wong, K., DeDecker, B., Henckel, J., & Fersht, A. R. (2000) · The EMBO Journal · doi:10.1093/emboj/19.3.370 · Cited by 152
From Alzheimer to Huntington: why is a structural understanding so difficult?
Temussi, P. A., Masino, L., & Pastore, A. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg044 · Cited by 148
Protein misfolding in Alzheimer’s and Parkinson’s disease: genetics and molecular mechanisms
Forloni, G., Terreni, L., Bertani, I., Fogliarino, S., Invernizzi, R. W., Assini, A., Ribizzi, G., Negro, A., Calabrese, E., Volonté, M. A., et al. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00076-3 · Cited by 147
Serpell, L. C., Sunde, M., Fraser, P. E., Luther, P. K., Morris, E. P., Sangren, O., Lundgren, E., & Blake, C. C. F. (1995) · Journal of Molecular Biology · doi:10.1006/jmbi.1995.0604 · Cited by 144
Lin, H., Sugimoto, Y., Ohsaki, Y., Ninomiya, H., Oka, A., Taniguchi, M., Ida, H., Eto, Y., Ogawa, S., Matsuzaki, Y., et al. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.03.007 · Cited by 125
Role of calnexin in the glycan‐independent quality control of proteolipid protein
Swanton, E., High, S., & Woodman, P. G. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg300 · Cited by 118
Role of quality control pathways in human diseases involving protein misfolding
Welch, W. J. (2004) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2003.12.011 · Cited by 110
Chaperone overload is a possible contributor to ‘civilization diseases’
Csermely, P. (2001) · Trends in Genetics · doi:10.1016/s0168-9525(01)02495-7 · Cited by 109
Goldfarb, L. G., Brown, P., Haltia, M., Cathala, F., McCombie, W. R., Kovanen, J., Červen̆áková, L., Goldin, L. R., Nieto, A., Godec, M. S., et al. (1992) · Annals of Neurology · doi:10.1002/ana.410310308 · Cited by 108
Zahn, R., Perrett, S., & Fersht, A. R. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0440 · Cited by 103
Unfolding retinal dystrophies: a role for molecular chaperones?
Chapple, J. P., Grayson, C., Hardcastle, A. J., Saliba, R. S., van der Spuy, J., & Cheetham, M. E. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02103-7 · Cited by 99
Mechanisms of Homogeneous Nucleation of Polymers of Sickle Cell Anemia Hemoglobin in Deoxy State
Galkin, O., & Vekilov, P. G. (2003) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.12.019 · Cited by 95
El‐Agnaf, O. M. A., & Irvine, G. B. (2000) · Journal of Structural Biology · doi:10.1006/jsbi.2000.4262 · Cited by 94
Yoshida, H., Yoshizawa, T., Shibasaki, F., Shoji, S., & Kanazawa, I. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0502 · Cited by 92
Del-Favero, J., Krols, L., Michalík, A., Theuns, J., Löfgren, A., Goossens, D., Wehnert, A., den Bossche, D. V., van Zand, K., Backhovens, H., et al. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.2.177 · Cited by 91
Peptide Inhibitors of Beta Amyloid Aggregation
Findeis, M. A. (2002) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026024607508 · Cited by 90
Higuchi, M., Iwata, N., & Saido, T. C. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2005.02.013 · Cited by 89
Aβ42-positive non-pyramidal neurons around amyloid plaques in Alzheimer's disease
Mochizuki, A., Tamaoka, A., Shimohata, A., Komatsuzaki, Y., & Shoji, S. (2000) · The Lancet · doi:10.1016/s0140-6736(99)04937-5 · Cited by 85
Forloni, G., Bertani, I., Calella, A. M., Thaler, F., & Invernizzi, R. W. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200005)47:5<632::aid-ana11>3.0.co;2-n · Cited by 82
Atherosclerosis: another protein misfolding disease?
Ursini, F., Davies, K. J. A., Maiorino, M., Parasassi, T., & Sevanian, A. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02382-1 · Cited by 80
Evert, B. O., Wüllner, U., Schulz, J. B., Weller, M., Groscurth, P., Trottier, Y., Brice, A., & Klockgether, T. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.7.1169 · Cited by 77
Wedi, B., Straede, J., Wieland, B., & Kapp, A. (1999) · Blood · doi:10.1182/blood.v94.7.2365.419k08_2365_2373 · Cited by 70
Jana, N. R., & Nukina, N. (2003) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(03)00029-2 · Cited by 67
Therapeutic approaches to repair defects in ΔF508 CFTR folding and cellular targeting
Powell, K., & Zeitlin, P. L. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00148-5 · Cited by 66
Sawano, H., Koumoto, Y., Ohta, K., Sasaki, Y., Segawa, S.-I., & Tachibana, H. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80466-t · Cited by 64
The Genetic Defect Causing Huntington’s Disease: Repeated in Other Contexts?
Gusella, J. F., Persichetti, F., & MacDonald, M. E. (1997) · Molecular Medicine · doi:10.1007/bf03401677 · Cited by 60
Seong, I. S., Oh, J. Y., Lee, J. W., Tanaka, K., & Chung, C. H. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01808-1 · Cited by 60
Heterogeneous AVPR2 gene mutations in congenital nephrogenic diabetes insipidus.
Wildin, R. S., Antush, M. J., Bennett, R. L., Schoof, J. M., & Scott, C. R. (1994) · PubMed Central · Cited by 58
Carrell, R. W., Lomas, D. A., Sidhar, S. K., & Foreman, R. C. (1996) · CHEST Journal · doi:10.1378/chest.110.6_supplement.243s · Cited by 57
Protective effect of chaperones on polyglutamine diseases
Kobayashi, Y., & Sobue, G. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00593-7 · Cited by 48
Kinjo, A. R., & Takada, S. (2003) · Biophysical Journal · doi:10.1016/s0006-3495(03)74772-9 · Cited by 47
Pathological glial tau accumulations in neurodegenerative disease: review and case report
Berry, R. W., Quinn, B., Johnson, N., Cochran, E. J., Ghoshal, N., & Binder, L. I. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(01)00054-7 · Cited by 46
Neurodegenerative conditions associated with ageing: a molecular interplay?
Troulinaki, K., & Tavernarakis, N. (2004) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.09.033 · Cited by 34
The Property of a Novel V2 Receptor Mutant in a Patient with Nephrogenic Diabetes Insipidus
Inaba, S., Hatakeyama, H., Taniguchi, N., & Miyamori, I. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.1.381 · Cited by 32
Diagnosis of “sporadic” Huntington's disease
Dürr, A., Dodé, C., Hahn‐Barma, V., Pécheux, C., Pillon, B., Feingold, J., Jc, K., Agid, Y., & Brice, A. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)00250-r · Cited by 31
Biochemical study on β-glucosidase in individuals with Gaucher's disease and normal subjects
Michelin, K., Wajner, A., Goulart, L. D. S., Fachel, Â. A., Pereira, M. L. S., de Mello, A. S., Souza, F. T. S., Pires, R. F., Giugliani, R., & Coelho, J. C. (2004) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.01.010 · Cited by 26
Raibekas, A. A., & Massey, V. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.35.22248 · Cited by 20
Manipulating the Folding Pathway of ΔF508 CFTR Using Chemical Chaperones
Howard, M., & Welch, W. J. (2003) · Humana Press eBooks · doi:10.1385/1-59259-187-6:267 · Cited by 13
De novo expansion of a CAG repeat in a Japanese patient with sporadic Huntington’s disease
Watanabe, M., Satoh, A., Kanemoto, M., Ohkoshi, N., & Shoji, S. (2000) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00368-3 · Cited by 10
Cited by
Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunities
Hu, C., Yang, J., Qi, Z., Wu, H., Wang, B., Zou, F., Mei, H., Liu, J., Wang, W., & Liu, Q. (2022) · MedComm · doi:10.1002/mco2.161 · Cited by 779
The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies
Maalouf, M., Rho, J. M., & Mattson, M. P. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.09.002 · Cited by 574
The Unfolded Protein Response: A Pathway That Links Insulin Demand with β-Cell Failure and Diabetes
Scheuner, D., & Kaufman, R. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0039 · Cited by 531
Challenges in application of Raman spectroscopy to biology and materials
Kuhar, N., Sil, S., Verma, T., & Umapathy, S. (2018) · RSC Advances · doi:10.1039/c8ra04491k · Cited by 334
Progressive damage after brain and spinal cord injury: pathomechanisms and treatment strategies
Bramlett, H. M., & Dietrich, W. D. (2007) · Progress in Brain Research · doi:10.1016/s0079-6123(06)61009-1 · Cited by 329
Metadata
- Authors
- Chaudhuri, T. K., & Paul, S.
- Venue
- The FEBS Journal
- Publisher
- Wiley
- Published
- 2006-04
- Volume
- 273
- Issue
- 7
- Pages
- 1331-1349
- ISSN
- 1742-464X (ISSN-L)
- 1742-4658
- OpenAlex
- W2111256689
- Cited by
- 419
- References
- 133
- FWCI
- 8.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.